(Q55071239)
Statements
1 reference
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†. (English)
1 reference
P A Fasching
1 reference
S Loibl
1 reference
M Untch
1 reference
G von Minckwitz
1 reference
H Eidtmann
1 reference
M Rezai
1 reference
H Tesch
1 reference
H Eggemann
1 reference
I Schrader
1 reference
K Kittel
1 reference
C Hanusch
1 reference
J Huober
1 reference
C Solbach
1 reference
C Jackisch
1 reference
G Kunz
1 reference
J U Blohmer
1 reference
M Hauschild
1 reference
T Fehm
1 reference
V Nekljudova
1 reference
B Gerber
1 reference
GBG/AGO-B study groups
1 reference
15 September 2014
1 reference
25
1 reference
12
1 reference
2363-2372
1 reference
Identifiers
1 reference